Human papillomavirus is a common virus that has been identified as the primary cause of cervical cancers and five other types of cancer: anal, vaginal, vulvar, penile and oropharyngeal. Despite nearly 15 years of research demonstrating the safety and efficacy of the HPV vaccine, U.S. vaccination rates remain significantly lower for HPV than for other recommended adolescent vaccines. As a result, increasing HPV vaccination for children and adolescents has the potential to prevent cancers in adulthood and save thousands of lives.
The HPV Cancer Prevention Program is focused on:
The St. Jude HPV Cancer Prevention Program is coordinating efforts to convene a “local” HPV vaccination roundtable in Memphis and Shelby County. Sign up here to participate!
The program is led by director Heather M. Brandt, PhD, a social and behavioral scientist and leader in cancer prevention and control, primarily in HPV vaccination and cervical cancer screening. Her research focuses on working with stakeholders to prevent and control cancer by using evidence-based interventions through innovative, partnered approaches. She is also a member of the Department of Epidemiology & Cancer Control.
In June 2018, the St. Jude Comprehensive Cancer Center, with National Cancer Institute (NCI)-designated cancer centers, endorsed the American Cancer Society’s goal of eliminating HPV-related cancers through vaccination and screening. This goal is part of the U.S. Department of Health and Human Services’ Healthy People 2020 objective.
As the only NCI-designated Comprehensive Cancer Center dedicated solely to children, St. Jude has an important role and responsibility in increasing the number of children who benefit from the HPV vaccine and reducing their risk of preventable cancers later in life. Moreover, St. Jude is located in Memphis with affiliate locations in the Mid-South region and southeastern U.S., an area with low HPV vaccination rates and a high HPV-associated cancer burden.
“As the only cancer center solely dedicated to children, we have a responsibility to lead the efforts to increase the vaccination rate in children, everywhere, so that we can prevent them from developing HPV-related cancers later in life,” said Charles Roberts, MD, PhD, director of the St. Jude Comprehensive Cancer Center and executive vice president at St. Jude. "HPV vaccination can have major impact on public health, as we could eliminate most cancers caused by HPV—but people have to get vaccinated.”
HPV Cancer Prevention Program
MS762, Room S3012
262 Danny Thomas Place
Memphis, TN 38105-1730
Phone: (901) 595-7615
Fax: (901) 595-1559
St. Jude is one of the world’s premier pediatric oncology research and treatment centers.
Read facts about cancer in children, including causes, treatments, statistics and information for survivors
St. Jude offers world-class scientific and clinical training experiences for fellows, students and other trainees. We also share knowledge through international outreach.
Browse the latest peer-reviewed articles from St. Jude investigators and clinicians, as well as breaking news, in-depth features and our Scientific Report.
Upcoming symposia and special seminars that will be held at St. Jude Children’s Research Hospital or are sponsored in part by in collaboration with other institutions.
St Jude is a world-class research hospital seeking a diverse staff of faculty, researchers, clinicians, fundraisers and more. Find a job and help save lives.